Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Nutrien
NTR
|
+$111M |
| 2 |
WP
Worldpay, Inc.
WP
|
+$37.6M |
| 3 |
Becton Dickinson
BDX
|
+$29.5M |
| 4 |
Alibaba
BABA
|
+$28.3M |
| 5 |
NXP Semiconductors
NXPI
|
+$24.5M |
Top Sells
| 1 |
Apple
AAPL
|
+$431M |
| 2 |
Microsoft
MSFT
|
+$315M |
| 3 |
Amazon
AMZN
|
+$278M |
| 4 |
Meta Platforms (Facebook)
META
|
+$170M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$150M |
Sector Composition
| 1 | Technology | 19.03% |
| 2 | Healthcare | 14.49% |
| 3 | Consumer Discretionary | 11.53% |
| 4 | Industrials | 10.4% |
| 5 | Communication Services | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1826
PetMed Express
PETS
$57.8M
| $1.5M | ﹤0.01% |
35,900
+2,100
| +6% | +$87.7K |
|
|
EXTN
1827
DELISTED
Exterran Corporation
EXTN
| $1.5M | ﹤0.01% |
56,150
+3,000
| +6% | +$80.1K |
|
|
FSP
1828
Franklin Street Properties
FSP
$174M
| $1.49M | ﹤0.01% |
177,463
+9,600
| +6% | +$80.7K |
|
|
SYNT
1829
DELISTED
Syntel Inc
SYNT
| $1.49M | ﹤0.01% |
58,300
+3,000
| +5% | +$76.6K |
|
|
EPZM
1830
DELISTED
Epizyme, Inc
EPZM
| $1.49M | ﹤0.01% |
83,700
| – | – |
|
1831
Editas Medicine
EDIT
$242M
| $1.49M | ﹤0.01% |
44,800
| – | – |
|
|
HIFR
1832
DELISTED
InfraREIT, Inc.
HIFR
| $1.48M | ﹤0.01% |
76,400
+3,500
| +5% | +$68K |
|
1833
CTS Corp
CTS
$1.23B
| $1.48M | ﹤0.01% |
54,500
+3,300
| +6% | +$89.7K |
|
1834
Evolent Health
EVH
$1.05B
| $1.48M | ﹤0.01% |
104,000
+4,800
| +5% | +$68.4K |
|
1835
Coca-Cola Consolidated
COKE
$10.6B
| $1.48M | ﹤0.01% |
85,650
| – | – |
|
1836
Perdoceo Education
PRDO
$2.26B
| $1.48M | ﹤0.01% |
112,500
| – | – |
|
1837
Cohen & Steers
CNS
$3.65B
| $1.48M | ﹤0.01% |
36,300
+2,100
| +6% | +$85.4K |
|
|
GTY
1838
Getty Realty Corp
GTY
$1.6B
| $1.48M | ﹤0.01% |
58,509
+2,400
| +4% | +$60.5K |
|
1839
Shake Shack
SHAK
$4.06B
| $1.47M | ﹤0.01% |
35,400
| – | – |
|
|
EGOV
1840
DELISTED
NIC Inc
EGOV
| $1.47M | ﹤0.01% |
110,800
| – | – |
|
|
RTEC
1841
DELISTED
Rudolph Technologies Inc
RTEC
| $1.47M | ﹤0.01% |
53,200
| – | – |
|
1842
Central Pacific Financial
CPF
$826M
| $1.47M | ﹤0.01% |
51,800
| – | – |
|
|
BMTC
1843
DELISTED
Bryn Mawr Bank Corp
BMTC
| $1.47M | ﹤0.01% |
33,500
+1,700
| +5% | +$74.7K |
|
1844
Preferred Bank
PFBC
$1.16B
| $1.47M | ﹤0.01% |
22,889
+1,500
| +7% | +$96.3K |
|
1845
TherapeuticsMD
TXMD
$12.8M
| $1.47M | ﹤0.01% |
6,028
+232
| +4% | +$56.5K |
|
|
CRAY
1846
DELISTED
Cray, Inc.
CRAY
| $1.46M | ﹤0.01% |
70,400
+3,300
| +5% | +$68.3K |
|
|
AVX
1847
DELISTED
AVX Corporation
AVX
| $1.46M | ﹤0.01% |
87,900
+3,500
| +4% | +$57.9K |
|
1848
LivePerson
LPSN
$86M
| $1.45M | ﹤0.01% |
88,900
| – | – |
|
|
LDL
1849
DELISTED
Lydall, Inc.
LDL
| $1.45M | ﹤0.01% |
30,100
+1,700
| +6% | +$82K |
|
1850
Banc of California
BANC
$2.62B
| $1.45M | ﹤0.01% |
75,100
| – | – |
|